Chat with us in Facebook Messenger. Find out what's happening in the world as it unfolds.

FILE - In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout Pharmaceuticals, the makers of the twice-rejected pill intended to boost libido in women, will make a third attempt this week at convincing regulators to approve the drug as the first prescription treatment for low sexual desire in women. A panel of FDA experts will discuss the drug at a public meeting Thursday, June 4, 2015 before voting on whether to recommend its approval.(AP Photo/Allen G. Breed, File)
FILE - In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout Pharmaceuticals, the makers of the twice-rejected pill intended to boost libido in women, will make a third attempt this week at convincing regulators to approve the drug as the first prescription treatment for low sexual desire in women. A panel of FDA experts will discuss the drug at a public meeting Thursday, June 4, 2015 before voting on whether to recommend its approval.(AP Photo/Allen G. Breed, File)

    JUST WATCHED

    'Female Viagra' gets FDA approval

MUST WATCH

'Female Viagra' gets FDA approval

CNN's Elizabeth Cohen reports the FDA has approved the drug flibanserin, dubbed "Viagra for women," to treat sexual dysfunction in premenopausal women.

'Female Viagra' gets FDA approval

CNN's Elizabeth Cohen reports the FDA has approved the drug flibanserin, dubbed "Viagra for women," to treat sexual dysfunction in premenopausal women.